Chronic Myelogenous Leukemia

Open studies are marked with a purple background, closed studies have a grey background, studies to be opened have a white background
06842
Phase II trial of human alpha-2 recombinant interferon for chronic myeloid leukemia in the chronic phase
06843
Phase II trial for the treatment of lymphoblastic transformation of chronic myeloid leukemia (LBT-CML)
06962
A randomized phase III study to assess intensification of the conditioning regimen for allogenic and autologous stem cell transplantation for myeloid and lymphoid malignancies with a high risk of relapse.
06941
A feasibility study for the therapy of chronic myeloid leukemia with recombinant Interferon Alpha plus All-Trans Retinoic Acid (ATRA)
06887
Randomized phase III study comparing hydroxyurea with Interferon alpha-2C in the chronic phase of chronic myeloid leukemia

Back to Site-list